Idenix v Gilead [2014] EWHC 3916 (Pat)

Andrew Lykiardopoulos QC, Tom Moody-Stuart and William Duncan all acted for Gilead (together with Justin Turner QC) in these patent infringement proceedings brought by Idenix in respect of Gilead’s product “Sovaldi” . The trial was heard over three weeks before Arnold J in 2014, who dismissed Idenix’s claims of patent infringement and held in favour of Gilead. The judge held that Sovaldi represents a significant breakthrough in the treatment of the Hepatitis C virus and that Idenix’s patent was invalid for novelty, lack of inventive step and insufficiency.
Andrew Lykiardopoulos QC, Tom Moody-Stuart and William Duncan were instructed by Herbert Smith Freehills LLP

View judgment